Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

Bruker Corp Aktie

Aktie
WKN:  813534 ISIN:  US1167941087 US-Symbol:  BRKR
40,44 $
+1,09 $
+2,77%
35,754 € 18:42:12 Uhr
Depot/Watchlist
Aktienanzahl *
151,60 Mio.
Marktkapitalisierung *
5,36 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 17.02.2025

Bruker Corp News

24.02.25 - wallstreetONLINE Redaktion
Räumliche Biologie?: Bruker: Hat Michael Burry eine Perle für sein Depot ausgegraben?
Michael Burry ist dafür bekannt große Risiken einzugehen. Zuletzt hat er für 4,4 Millionen US-Dollar Aktien von Bruker gekauft. Ist der Kauf riskant oder hat Burry als ausgebildeter ...
17.02.25 - wallstreetONLINE Redaktion
Alibaba, JD.com & Co: Michael Burry kappt seine China-Wetten und kauft stattdessen gecrashte US-Aktien
Der legendäre Investor Michael Burry, bekannt für seine Vorhersage der Subprime-​Krise, hat sein Portfolio radikal umgebaut und seine Wetten auf chinesische Internetaktien neu ...
23.12.24 - PR Newswire
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products PR Newswire
15.02.24 - wallstreetONLINE Redaktion
"The Big Short"-Investor: Aktien-Crash? Michael Burry setzt jetzt auf Chinas Big-Tech!
Michael Burry hat zuletzt massiv auf chinesische Tech-​Aktien gesetzt. Burry wurde bekannt, als er 2007 das Platzen der Immobilienblase voraussagte. Jetzt scheint er deutlich ...
27.11.23 - PR Newswire
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper® PR Newswire
05.09.23 - PR Newswire
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker PR Newswire
20.07.22 - PR Newswire
Acuamark Diagnostics sichert sich 11,3 Millionen Dollar für Serie A-Finanzierung, um innovative Assays für verbesserte, kosteneffektive Krebsfrüherkennung voranzutreiben
Acuamark Diagnostics sichert sich 11,3 Millionen Dollar für Serie A-​Finanzierung, um innovative Assays für verbesserte, kosteneffektive Krebsfrüherkennung voranzutreiben PR ...
20.07.22 - PR Newswire
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-​Effective Early-​Cancer Detection PR Newswire
20.07.22 - PR Newswire
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-​Effective Early-​Cancer Detection PR Newswire
24.11.21 - PR Newswire
Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600
Bruker BioSciences Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
29.03.21 - Newsfile
Cambridge Isotope Laboratories, Inc and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL's NMR Solvents
Cambridge Isotope Laboratories, Inc. (CIL) is entering a global, strategic partnership with Bruker BioSpin for the distribution of CIL's NMR Solvents
10.03.21 - PR Newswire
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-Based Assays for Liver Fibrosis, Cirrhosis and Liver Cancer (HCC)
GlycoPath Inc. Secures Seed Investment to Further Develop, Validate and Commercialize GlycoTyper™ Mass Spectrometry-​Based Assays for Liver Fibrosis, Cirrhosis and Liver ...
12.04.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR PR Newswire
12.04.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bruker Corporation - BRKR PR Newswire
06.03.20 - PR Newswire
Investor Alert: Kaplan Fox Investigates Bruker Corporation
Investor Alert: Kaplan Fox Investigates Bruker Corporation PR Newswire
04.03.20 - PR Newswire
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating Possible Securities Law Violations
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bruker Corporation (BRKR) Investors Who Have Suffered Losses to Contact its Attorneys: Firm Investigating ...
30.12.19 - PR Newswire
Bruker Corporation to Present at the 38th Annual J.P. Morgan Healthcare Conference
Bruker Corporation to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
12.12.19 - PR Newswire
Bruker Completes Debt Financing to Support Corporate Strategic Objectives
Bruker Completes Debt Financing to Support Corporate Strategic Objectives PR Newswire
09.12.19 - PR Newswire
Bruker Introduces Dedicated Light-Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging
Bruker Introduces Dedicated Light-​Sheet Microscope for Highly Multiplexed 3D Cell Culture Live Imaging Luxendo TruLive3D Imager Enables Rapid Imaging of Cells and Organoids ...
15.11.19 - PR Newswire
Bruker Corporation to Present at Investor Conferences
Bruker Corporation to Present at Investor Conferences PR Newswire

Newssuche

Videos

newspaper
30.04.25 +13,48%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »